메뉴 건너뛰기
The Lancet Oncology
Volumn 15, Issue 4, 2014, Pages 372-374
Radiotherapy for indolent lymphomas: How much is enough?
Author keywords

[No Author keywords available]
Indexed keywords

CANCER CONTROL; CANCER GRADING; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; FOLLICULAR LYMPHOMA; HISTOLOGY; HUMAN; NOTE; PHASE 2 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; RADIATION DOSE; RADIOSENSITIVITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT DURATION; TREATMENT RESPONSE;
EID: 84897415086     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(14)70070-1     Document Type: Note
Times cited : (4)
References (8)
  • 1
    • 80051793679 scopus 로고    scopus 로고
    • Reduced dose radiotherapy for local control in non-Hodgkin lymphoma: a randomised phase III trial
    • Lowry L, Smith P, Qian W, et al. Reduced dose radiotherapy for local control in non-Hodgkin lymphoma: a randomised phase III trial. Radiother Oncol 2011, 100:86-92.
    • (2011) Radiother Oncol , vol.100 , pp. 86-92
    • Lowry, L.1    Smith, P.2    Qian, W.3
  • 2
    • 84897387358 scopus 로고    scopus 로고
    • Modern radiation therapy for nodal non Hodgkin lymphoma-target definition and dose guidelines from the International Lymphoma Radiation Oncology Group (ILROG)
    • (in press).
    • Illidge T, Specht L, Yahalom J, et al. Modern radiation therapy for nodal non Hodgkin lymphoma-target definition and dose guidelines from the International Lymphoma Radiation Oncology Group (ILROG). Int J Radiat Oncol Biol Phys 2014, (in press).
    • (2014) Int J Radiat Oncol Biol Phys
    • Illidge, T.1    Specht, L.2    Yahalom, J.3
  • 3
    • 0038352170 scopus 로고    scopus 로고
    • High response rates and lasting remissions after low-dose involved field radiotherapy in indolent lymphomas
    • Haas RL, Poortmans P, de Jong D, et al. High response rates and lasting remissions after low-dose involved field radiotherapy in indolent lymphomas. J Clin Oncol 2003, 21:2474-2480.
    • (2003) J Clin Oncol , vol.21 , pp. 2474-2480
    • Haas, R.L.1    Poortmans, P.2    de Jong, D.3
  • 4
    • 84897456841 scopus 로고    scopus 로고
    • 4 Gy versus 24 Gy radiotherapy for patients with indolent lymphoma (FORT): a randomised phase 3 non-inferiority trial
    • published online Feb 24.
    • Hoskin PJ, Kirkwood AA, Popova B, et al. 4 Gy versus 24 Gy radiotherapy for patients with indolent lymphoma (FORT): a randomised phase 3 non-inferiority trial. Lancet Oncol 2014, published online Feb 24. http://dx.doi.org/10.1016/S1470-2045(14)70036-1.
    • (2014) Lancet Oncol
    • Hoskin, P.J.1    Kirkwood, A.A.2    Popova, B.3
  • 5
    • 84891854829 scopus 로고    scopus 로고
    • Interactive decision-support tool for risk-based radiation therapy plan comparison for Hodgkin lymphoma
    • Brodin NP, Maraldo MV, Aznar MC, et al. Interactive decision-support tool for risk-based radiation therapy plan comparison for Hodgkin lymphoma. Int J Radiat Oncol Biol Phys 2014, 88:433-445.
    • (2014) Int J Radiat Oncol Biol Phys , vol.88 , pp. 433-445
    • Brodin, N.P.1    Maraldo, M.V.2    Aznar, M.C.3
  • 6
    • 84889844937 scopus 로고    scopus 로고
    • Dissecting the gray zone between follicular lymphoma and marginal zone lymphoma using morphological and genetic features
    • Krijgsman O, Gonzalez P, Ponz OB, et al. Dissecting the gray zone between follicular lymphoma and marginal zone lymphoma using morphological and genetic features. Haematologica 2013, 98:1921-1929.
    • (2013) Haematologica , vol.98 , pp. 1921-1929
    • Krijgsman, O.1    Gonzalez, P.2    Ponz, O.B.3
  • 7
    • 23644439927 scopus 로고    scopus 로고
    • Effective palliation by low dose local radiotherapy for recurrent and/or chemotherapy refractory non-follicular lymphoma patients
    • Haas RL, Poortmans P, de Jong D, et al. Effective palliation by low dose local radiotherapy for recurrent and/or chemotherapy refractory non-follicular lymphoma patients. Eur J Cancer 2005, 41:1724-1730.
    • (2005) Eur J Cancer , vol.41 , pp. 1724-1730
    • Haas, R.L.1    Poortmans, P.2    de Jong, D.3
  • 8
    • 60849120820 scopus 로고    scopus 로고
    • Efficacy of palliative low-dose involved-field radiation therapy in advanced lymphoma: a phase II study
    • Murthy V, Thomas K, Foo K, et al. Efficacy of palliative low-dose involved-field radiation therapy in advanced lymphoma: a phase II study. Clin Lymphoma Myeloma 2008, 8:241-245.
    • (2008) Clin Lymphoma Myeloma , vol.8 , pp. 241-245
    • Murthy, V.1    Thomas, K.2    Foo, K.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.